Abstract
Several lines of evidence suggest that carbamazepine (Tegretol), an anticonvulsant effective in the treatment of major motor and psychomotor seizures, might represent a new type of drug useful in the treatment of patients with affective illness. While the structure of carbamazepine is similar to imipramine and chlorpromazine, its mechanism of action appears to be different from that of either classic tricyclic or neuroleptic medications1–3. Dalby4 reviewed the research of 40 studies which together included 2500 seizure patients treated with carbamazepine. In most of these studies, there was an improvement in mood and behavior. In addition, Dalby5 himself reported that symptoms of episodic depression improved in 11 of 18 psychomotor epileptic patients treated with open carbamazepine. The improvement in depression and manic-like behavior with carbamazepine therapy in some cases was not associated with an equally robust control of seizures. Dalby’s5 observations suggested that carbamazepine might have psychotropic properties independent of its effects on clinical seizure control. Consistent with this hypothesis, numerous studies have demonstrated carbamazepine[1]s efficacy in the treatment of neurological syndromes unrelated to a seizure diathesis such as trigeminal, glossopharyngeal, and post-herpetic neuralgias. Furthermore, Takazaki and Hanaoka6 and Okuma and colleagues7 found that open carbamazepine had positive psychotropic effects in psychiatric patients without overt organic lesions or epilepsy. While carbamazepine’s psychotropic and analgesic properties clearly are not related directly to improved seizure control, its “stabilizing” effects on limbic substrates may be pertinent in this regard.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.E. Purdy, R.M. Julien, A.S. Fairhurst, and M.D. Terry, Effect of carbamazepine on thein vitro uptake and release of norepinephrine in adrenergic nerves of rabbit aorta and in whole brain synaptosomes,Epilepsia 18: 251 (1977).
R.M. Post, T.W. Uhde, and J.C. Ballenger, Efficacy of carbamazepine in affective disorders: implications for underlying physiological and biochemical substrates,in “Proceedings, Symposium on the Use of Anticonvulsants in Affective Disorders, VII World Congress of Psychiatry,” H.M. Emrich, ed., Excerpta Medica, Amsterdam (1983).
P.J. Marangos, R.M. Post, J. Patel, K. Zander, A. Parma, and S. Weiss, Specific and potent interactions of carbamazepine with brain adenosine receptors,Eur. J. Pharmacol. (1983, in press).
M.A. Dalby, Behavioral effects of carbamazepine,in “Complex Partial Seizures and Their Treatment: Advances in Neurology, Vol. 11”, J.K. Penry and D.D. Daly, eds., Raven Press, New York (1975).
M.A. Dalby, Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy.Epilepsia 12: 325 (1971).
H. Takezaki and M. Hanaoka, The use of carbamazepine (Tegretol) in the control of manic-depressive psychosis and other manic- depressive states.Clin. Psychiatry 13: 173 (1971).
T. Okuma, A. Kishimoto, K. Inoue, H. Matsumoto, A. Ogura, T. Matsushita, T. Naklao, and C. Ogura, Anti-manic and prophylactic effects of carbamazepine on manic-depressive psychosis.Folia Psychiatr. Neurol. Jpn 27: 283 (1973).
J.A. Wada, Pharmacological prophylaxis in the kindling model of epilepsy,Arch. Neurol. 34: 389 (1977).
T.E. Albertson, S.L. Peterson, and L.G. Stark, Anticonvulsant drugs and their antagonism of kindled amygdaloid seizures in rats,Neuropharmacology 19: 643 (1980).
R.M. Post, J.C. Ballenger, T.W. Uhde, and W.E. Bunney, Jr., Carbamazepine in manic-depressive illness: implications for underlying mechanisms,in “Neurobiology of Mood Disorders”, R.M. Post and J.C. Ballenger, eds., Williams & Wilkins, Baltimore (1983).
J.W. Papez, A proposed mechanism of emotion,Arch. Neurol. Psychiatry 38: 725 (1937).
P.D. MacLean, A triune concept of the brain and behavior, in “The Clarence M. Hicks Memorial Lectures, 1969,” T.J. Boag and D. Campbell, eds., University of Toronto Press, Toronto (1975).
P.S. Albright and W.M. Burnham, Development of a new pharmacological seizure model: effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat,Epilepsia 21: 681 (1980).
J.C. Ballenger and R.M. Post, Therapeutic effects of carbamazepine in affective illness: a preliminary report,Commun. Psychopharmacology 2: 159 (1978).
R.M. Post, T.W. Uhde, J.C. Ballenger, and W.E. Bunney, Jr.,Carbamazepine, temporal lobe epilepsy, and manic-depressive illness,in “Advances in Biological Psychiatry, Vol. 8: Temporal Lobe Epilepsy, Mania, and Schizophrenia and the Limbic System,” W.P. Koella and M.R. Trimble, eds., S. Karger AG, Basel (1982).
T.W. Uhde, R.M. Post, J.C. Ballenger, and J.-P. Boulenger, Carbamazepine (Tegretol) in the treatment of neuropsychiatric disorders,in “Proceedings, Symposium on the Use of Anticonvulsants in Affective Disorders, VII World Congress of Psychiatry,” H.M. Emrich, ed., Excerpta Medica, Amsterdam (1983, in press).
R.M. Post and T.W. Uhde, Carbamazepine in the treatment of mood and anxiety disorders,in “Psychopharmacology of the Limbic System,” M. Trimble and E. Zarifian, eds., John Wiley & Sons, Ltd., New York (1983, in press).
R.M. Post, T.W. Uhde, J.C. Ballenger, and K.M. Squillace, Prophylactic efficacy of carbamazepine in manic-depressive illness.Am. J. Psychiatry (1983, in press).
R.M. Post, T.W. Uhde, J.C. Ballenger, D.C. Chatterji, R.F. Green and W.E. Bunney, Jr., Carbamazepine and its -10,11-epox- ide metabolite in plasma and CSF: relationship to antidepressant response,Arch. Gen. Psychiatry 40: 673 (1983).
T.W. Uhde and R.M. Post, Effects of carbamazepine on serum electrolytes: clinical and theoretical implications.J. Clin. Psychopharmacology 3: 103 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Uhde, T.W., Ballenger, J.C., Post, R.M. (1985). Carbamazepine: Treatment of Affective Illness and Anxiety Syndromes. In: Pichot, P., Berner, P., Wolf, R., Thau, K. (eds) Psychiatry the State of the Art. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2363-1_75
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2363-1_75
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9446-7
Online ISBN: 978-1-4613-2363-1
eBook Packages: Springer Book Archive